Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06912737 · ClinicalTrials.gov registry record · NA
Group Emotion-Focused Behavioral Intervention for Diabetes Distress/A1c in T2D.
A NA study, sponsored by Ohio State University.
- Not yet
- Registry status
- NA
- Development phase
- 120
- Enrollment target
NCT06912737 is a NA study that has not yet begun recruiting, run by Ohio State University. The registered enrollment target is 120 participants.
The verdict
NCT06912737, a NA study, has not yet begun recruiting, sponsored by Ohio State University.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 120 participants
- Enrollment target
Study Summary
T2D is a major public health problem and is currently the 7th leading cause of death in the US. Despite a range of efficacious treatments, less than 50% of patients achieve a glycemic target of A1c \< 7.0%, suggesting that this is due to difficulty with following medical regimens to reduce A1C levels. While a range of factors have been identified in this regard, we posit that a barrier to treatment are broad difficulty with emotional regulation that are not diagnosis-specific but lead to Diabetes Distress (DD) and difficulty in coping with medical regimens, and other aspects of diabetes self-care, in the context of the psychosocial stressors associated with T2D. Extant data suggests that sub-optimal emotional regulation (experience of intense emotion and skill at regulating emotion) is related to elevated DD and A1c levels, and that an Emotion-Focused Behavioral Intervention (EFBI) can reduce both DD and A1c levels in PWD with T2D. In this project we seek to take our one-to-one intervention, now adapted to a group intervention (G-EFBI) and collect feasibility, acceptability, and preliminary efficacy data to determine if G-EFBI is a feasible, acceptable and, possibly, efficacious intervention compared to an "Attentional Control" intervention in PWD with T2D and elevated DD and A1c levels.
Interventions
- BEHAVIORAL Group Emotion Focused Behavioral Intervention (G-EFBI)
- BEHAVIORAL Group - With Every Heartbeat is Life (G-WEHL)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2025-09-01 |
| Est. Completion | 2028-01-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06912737
The ClinicalTrials.gov registry entry for NCT06912737 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ohio State University, which has 552 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Group Emotion Focused Behavioral Intervention (G-EFBI) is the first listed.
NCT06912737 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06912737 about?
NCT06912737 is a clinical study titled "Group Emotion-Focused Behavioral Intervention for Diabetes Distress/A1c in T2D.". T2D is a major public health problem and is currently the 7th leading cause of death in the US. Despite a range of efficacious treatments, less than 50% of patients achieve a glycemic target of A1c \< 7.0%, suggesting that this is due to difficulty with following medical regimens to reduce A1C level...
What is the current status of trial NCT06912737?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 120 participants. The study started on 2025-09-01. Estimated completion is 2028-01-31.
What interventions are being tested in trial NCT06912737?
The interventions under investigation include: Group Emotion Focused Behavioral Intervention (G-EFBI) (BEHAVIORAL), Group - With Every Heartbeat is Life (G-WEHL) (BEHAVIORAL).
Who is sponsoring clinical trial NCT06912737?
This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.